Dear Friends, A recent FDA decision denied approval of a promising new treatment called RP1 for advanced melanoma—one that showed encouraging results for patients who had failed first-line therapy. Read more about the denial here. Because the treatment could save lives, we feel compelled to appeal to the FDA. We need your help. Your experience with melanoma — whether you ... Read More
